These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33017380)

  • 41. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusion.
    Astam N; Batioğlu F; Ozmert E
    Int Ophthalmol; 2009 Oct; 29(5):343-8. PubMed ID: 18553061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single intravitreal bevacizumab injection effects on contrast sensitivity in macular edema from branch retinal vein occlusion.
    Preti RC; Ramirez LM; Pimentel SL; Motta AA; Machado CG; Monteiro ML; Takahashi WY
    Arq Bras Oftalmol; 2012; 75(1):29-32. PubMed ID: 22552414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of Ranibizumab and Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion.
    Son BK; Kwak HW; Kim ES; Yu SY
    Korean J Ophthalmol; 2017 Jun; 31(3):209-216. PubMed ID: 28471106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparative study between intravitreal triamcinolone and bevacizumab for macular edema due to central retinal vein occlusion with poor vision.
    Lim JW; Na KI
    Indian J Ophthalmol; 2011; 59(2):93-6. PubMed ID: 21350277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical, anatomical, and electrophysiological assessments of the central retina following intravitreal bevacizumab for macular edema secondary to retinal vein occlusion.
    Loukianou E; Brouzas D; Chatzistefanou K; Koutsandrea C
    Int Ophthalmol; 2016 Feb; 36(1):21-36. PubMed ID: 25820576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months.
    Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
    Retina; 2010; 30(7):1002-11. PubMed ID: 20616679
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.
    Lin CJ; Chen HS; Su CW; Tien PT; Lin JM; Chen WL; Kuo CY; Lai CT; Tsai YY
    J Ocul Pharmacol Ther; 2017 Dec; 33(10):763-772. PubMed ID: 28949790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aflibercept for Previously Treated Macular Edema Associated with Central Retinal Vein Occlusions: 1-Year Results of the NEWTON Study.
    Khurana RN; Chang LK; Bansal AS; Palmer JD; Wu C; Wieland MR
    Ophthalmol Retina; 2018 Feb; 2(2):128-133. PubMed ID: 31047339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion-related macular edema: A systematic review and meta-analysis of randomized controlled trials.
    Hu Q; Li H; Xu W; Du Y; Ma C; He J
    Indian J Ophthalmol; 2019 Nov; 67(11):1800-1809. PubMed ID: 31638037
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
    Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
    Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes of Combination Therapy using Aflibercept and Dexamethasone Intravitreal Implant versus Dexamethasone Monotherapy for Macular Edema Secondary to Retinal Vein Occlusion.
    Harb W; Chidiac G; Harb G
    Middle East Afr J Ophthalmol; 2021; 28(1):18-22. PubMed ID: 34321818
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiographically Documented Macular Ischemia after Single Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion.
    Lee KH; Kang EC; Koh HJ
    Yonsei Med J; 2017 May; 58(3):676-678. PubMed ID: 28332380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab.
    Yoo SG; Kim JH; Lee TG; Kim CG; Kim JW
    Indian J Ophthalmol; 2015 Jan; 63(1):25-9. PubMed ID: 25686058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
    Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
    Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid resolution of macular edema associated with central retinal vein occlusion using ranibizumab after failure with multiple bevacizumab injections.
    Labriola LT; Sadda SR
    Semin Ophthalmol; 2011 Nov; 26(6):387-91. PubMed ID: 22044337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion.
    de Salles MC; Epstein D
    Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2653-2660. PubMed ID: 33738625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Macular hole after injection of dexamethasone intravitreal implant for macular oedema due to central retinal vein occlusion.
    De Benedetto U; Battaglia Parodi M; Knutsson KA; Lattanzio R; Bandello F; Iacono P
    Acta Ophthalmol; 2013 Feb; 91(1):e75-7. PubMed ID: 22863290
    [No Abstract]   [Full Text] [Related]  

  • 59. Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study.
    Li X; Wang N; Liang X; Xu G; Li XY; Jiao J; Lou J; Hashad Y;
    Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):59-69. PubMed ID: 29119239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The efficacy of intravitreal dexamethasone implant as the first-line treatment for retinal vein occlusion-related macular edema in a real-life scenario.
    Simsek M; Citirik M; Ozates S; Ozkoyuncu D
    Indian J Ophthalmol; 2018 Jun; 66(6):831-836. PubMed ID: 29785994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.